Arkolith/Insider Trading/ALZN/Form 4

Ault Milton C III

Director, 10% OwnerAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed Jul 29, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$128K
Net Open-Market Flow
-$128K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 28, 2025Sell(S)8K$2.68$22K38K
Jul 25, 2025Sell(S)37K$2.90$106K46K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-011043) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML